FACT Board members met during the TCT Meetings with its newest accreditation partner, Sociedade Brasileira de Transplante de Medula Óssea (SBTMO) to continue planning to assist Brazilian transplant centers to achieve FACT-SBTMO Accreditation.
Andrea Kondo, who is a member of SBTMO and is part of the Accreditation Committee, was responsible for presenting to the Latin American Bone Marrow Transplant Group (LABMT) during the TCT Meetings the steps already taken in the FACT-SBTMO Accreditation Program. Dr. Kondo announded there are already 24 hematopoietic stem cell transplant centers that want to participate in the program and achieve certification. This is because “the accreditation attests to the institution that it offers safety, excellence and quality in each of the processes practiced by it, not only in the part of the clinical program, but also in the collection of progenitor cell products, in the processing and infusion of cells -trunk, ”explains Andrea.
“These centers that have already joined and the others that have been contacting us, show us that there is really a movement to strengthen and improve our HSCT practice, which is a gain not only for services, but especially for patients” declared the president of SBTMO, Nelson Hamerschlak.
It is worth mentioning that Brazil was the pioneer in Latin America, since 2012, to gain FACT recognition, through the accreditation of Hospital Israelita Albert Einstein (HIAE), which has been re-accredited in 2015 and 2018.
Educational efforts to support the Brazilian centers in preparing for accreditation are underway. Andrea Kondo is currently working on the development of educational tools and webinars to assist transplant centers. Planning is underway for a FACT Inspection & Accreditation workshop scheduled to take place during the SBTMO Annual Congress slated for October 2020 in Sao Paolo.
Approximately 70 representatives of bone marrow transplant centers attended the FACT-SBTMO Accreditation Program Workshop on July 31, 2019; an initiative that is the result of the partnership between the Brazilian Society of Bone Marrow Transplant (SBTMO) and the Foundation for the Accreditation of Cellular Therapy.
The meeting clarified the requirements and the operational dynamics of the accreditation process for Brazilian cell therapy transplant centers.
As Carlos Bachier and Phyllis Warkentin of the FACT Global Accreditation Committee have reported, it may seem complex at first, but it is certainly possible to complete each of the gradual steps in the process toward accreditation.
The accreditation will be valid for 3 years. The estimated time to complete the initial certification cycle is 2 years. The program was designed taking into account the structure and operations of the Brazilian centers, including the interest of the 39 TMO centers that responded to the SBTMO Online Survey distributed to gather the demographics of the national transplant programs.
For over 20 years, FACT has established international standards for the collection, processing and administration of hematopoietic cell therapy products. It is worth mentioning that Brazil was the pioneer in Latin America when in 2012 Hospital Israelita Albert Einstein (HIAE) was awarded FACT accreditation. Albert Einstein has been re-accredited in 2015 and 2018.
In addition to Brazil, FACT has accredited 255 cell therapy programs in 6 countries: Canada, Mexico, New Zealand, Australia, Singapore, United States.
It is noteworthy that FACT accreditation is based on the FACT-JACIE (The Joint Accreditation Committee ISCT-Europe & EBMT) Standards, which is Europe’s only official accreditation body in the field of HSCT and cell therapy.
Expression of Interest
If you wish to express your interest in joining the accreditation program in Brazil, please send the following data to SBTMO – via email@example.com or FACT – via firstname.lastname@example.org
- Transplant Center Name
- Name of Contact Person
- Full address
Put in the subject line of the message : “FACT-SBTMO Accreditation”
Members of the Sociedade Brasileira de Transplante de Medula Óssea (SBTMO) are invited to attend the FACT-SBTMO Cell Therapy Accreditation Workshop on Wednesday, July 31, 2019 during the XXIII Congresso da SBTMO in Brasília.
The blood and marrow transplantation field has been a leader in voluntarily improving quality through FACT accreditation. This workshop will address important topics in the cellular therapy field including the requirements of the FACT-SBTMO joint cell therapy accreditation program in Brazil. FACT and SBTMO representatives will be in attendance to:
• Provide an overview of the FACT International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration and accreditation process
• Explain how to integrate quality management into clinical, collection, and cell processing programs
• Examine how to prepare for a successful inspection
• Summarize how controlling documentation can improve your program
• Share the experience of an accredited Brazilian transplant center
• Review commonly cited Standards
• Outline the inspector orientation process
• Answer questions
Date: July 31, 2019
Time: 8:00 to 13:15
Location: Hotel Royal Tulip Brasília Alvorada
SHTN Trecho 1 Blocos C Conj. 1 – Asa Norte
Brasília -DF 70800-200